MedDataX Logo

A Descriptive Study to Explore Certain Characteristics of Patients at Risk for Chronic Obstructive Pulmonary Disease (COPD) in a Primary Care Setting

NCT ID: NCT01013922

Last Updated: 2010-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

309 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-10-31

Study Completion Date

2010-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to explore if certain characteristics, easily detected within a regular primary care setting, may indicate that a patient at risk for COPD (45 ≤ age ≤ 80 years and a smoking history of ≥ 15 pack years) is prone to have a diagnosis of COPD according to Medical Products Agency guidelines.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

COPD COPD-6 Spirometry VC FEV FEV1

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No treatment

Patients with a smoking history of 15 pack years or more.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with a history of smoking one pack of cigarettes per day for 15 years or more

Exclusion Criteria

* Known Chronic Obstructive Pulmonary Disease
* Known severe cardiovascular disease
Minimum Eligible Age

45 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

AstraZeneca

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Björn Tilling

Role: PRINCIPAL_INVESTIGATOR

Åtvidabergs vårdcentral

Georgios Stratelis

Role: STUDY_DIRECTOR

AstraZeneca

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Alingsås, , Sweden

Site Status

Research Site

Arvidsjaur, , Sweden

Site Status

Research Site

Askim, , Sweden

Site Status

Research Site

Åtvidaberg, , Sweden

Site Status

Research Site

Bromma, , Sweden

Site Status

Research Site

Eslöv, , Sweden

Site Status

Research Site

Falun, , Sweden

Site Status

Research Site

Gagnef, , Sweden

Site Status

Research Site

Gothenburg, , Sweden

Site Status

Research Site

Hagfors, , Sweden

Site Status

Research Site

Helsingborg, , Sweden

Site Status

Research Site

Hisings Kärra, , Sweden

Site Status

Research Site

Höllviken, , Sweden

Site Status

Research Site

Järpen, , Sweden

Site Status

Research Site

Karlshamn, , Sweden

Site Status

Research Site

Karlskrona, , Sweden

Site Status

Research Site

Kil, , Sweden

Site Status

Research Site

Limhamn, , Sweden

Site Status

Research Site

Linköping, , Sweden

Site Status

Research Site

Luleå, , Sweden

Site Status

Research Site

Stockholm, , Sweden

Site Status

Research Site

Timrå, , Sweden

Site Status

Research Site

Värnamo, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

References

Explore related publications, articles, or registry entries linked to this study.

Thorn J, Tilling B, Lisspers K, Jorgensen L, Stenling A, Stratelis G. Improved prediction of COPD in at-risk patients using lung function pre-screening in primary care: a real-life study and cost-effectiveness analysis. Prim Care Respir J. 2012 Jun;21(2):159-66. doi: 10.4104/pcrj.2011.00104.

Reference Type DERIVED
PMID: 22270480 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-RSE-DUM-2008/1

Identifier Type: -

Identifier Source: org_study_id